Abstract
A majority of previous studies have shown the effectiveness of nitroimidazole derivatives, metronidazole and Ro-07-0582, in specifically sensitizing the hypoxic cell componenet of solid tumours to single doses of irradiation. The present study investigated the effects of nitroimadazoel Ro-07-0582 (0.75 mg/g) on the growth of MNU fibrosarcoma when administered with fractionated radiation therapy. Delay of tumour regrowth was recorded and was compared to single dose experiments using the sensitizer. The results show that fractionated radiotherapy with the sensitizer has an advantage over fractionated therapy alone (delay factor 1.58), but not over single dose therapy with the sensitizer (delay factor 2.6). This difference may be due to the sublethal repair from re-oxygenation in fractionated radiotherapy.
Full text
PDF




Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- ADAMS G. E., DEWEY D. L. HYDRATED ELECTRONS AND RADIOBIOLOGICAL SENSITISATION. Biochem Biophys Res Commun. 1963 Aug 20;12:473–477. doi: 10.1016/0006-291x(63)90318-8. [DOI] [PubMed] [Google Scholar]
- Asquith J. C., Watts M. E., Patel K., Smithen C. E., Adams G. E. Electron affinic sensitization. V. Radiosensitization of hypoxic bacteria and mammalian cells in vitro by some nitroimidazoles and nitropyrazoles. Radiat Res. 1974 Oct;60(1):108–118. [PubMed] [Google Scholar]
- Denekamp J., Harris S. R. The response of a transplantable tumor to fractionated irradiation. 1. X rays and the hypoxic cell radiosensitizer Ro-07-0582. Radiat Res. 1976 Apr;66(1):66–75. [PubMed] [Google Scholar]
- Denekamp J., Michael B. D., Harris S. R. Hypoxic cell radiosensitizers: comparative tests of some electron affinic compounds using epidermal cell survival in vivo. Radiat Res. 1974 Oct;60(1):119–132. [PubMed] [Google Scholar]
- Denekamp J., Michael B. D. Preferential sensitization of hypoxic cells to radiation in vivo. Nat New Biol. 1972 Sep 6;239(88):21–23. doi: 10.1038/newbio239021a0. [DOI] [PubMed] [Google Scholar]
- Dische S., Gray A. J., Zanelli G. D. Clinical testing of the radiosensitiser Ro-07-0582. II. Radiosensitisation of normal and hypoxic skin. Clin Radiol. 1976 Apr;27(2):159–166. doi: 10.1016/s0009-9260(76)80138-9. [DOI] [PubMed] [Google Scholar]
- Field S. B., Jones T., Thomlinson R. H. The relative effects of fast neutrons and x rays on tumour and normal tissue in the rat. II. Fractionation: recovery and reoxygenation. Br J Radiol. 1968 Aug;41(488):597–607. doi: 10.1259/0007-1285-41-488-597. [DOI] [PubMed] [Google Scholar]
- Foster J. L., Conroy P. J., Searle A. J., Willson R. L. Metronidazole (Flagyl): characterization as a cytotoxic drug specific for hypoxic tumour cells. Br J Cancer. 1976 May;33(5):485–490. doi: 10.1038/bjc.1976.78. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fowler J. F., Adams G. E. Proceedings: Radiosensitization of hypoxic cells in solid tumours in mice. Br J Radiol. 1975 Jan;48(565):77–78. [PubMed] [Google Scholar]
- Fowler J. F., Sheldon P. W., Denekamp J., Field S. B. Optimum fractionation of the C3H mouse mammary carcinoma using x-rays, the hypoxic-cell radiosensitizer Ro-07-0582, or fast neutrons. Int J Radiat Oncol Biol Phys. 1976 Jul-Aug;1(7-8):579–592. doi: 10.1016/0360-3016(76)90139-5. [DOI] [PubMed] [Google Scholar]
- Gray A. J., Dische S., Adams G. E., Flockhart I. R., Foster J. L. Clinical testing of the radiosensitiser Ro-07-0582. I. Dose tolerance, serum and tumour concentrations. Clin Radiol. 1976 Apr;27(2):151–157. doi: 10.1016/s0009-9260(76)80137-7. [DOI] [PubMed] [Google Scholar]
- Moore B. A., Palcic B., Skarsgard L. D. Radiosensitizing and toxic effects on the 2-nitroimidazole Ro-07-0582 in hypoxic mammation cells. Radiat Res. 1976 Sep;67(3):459–473. [PubMed] [Google Scholar]
- Sheldon P. W., Foster J. L., Fowler J. F. Radiosensitization of C3H mouse mammary tumours by a 2-nitroimidazole drug. Br J Cancer. 1974 Dec;30(6):560–565. doi: 10.1038/bjc.1974.235. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sheldon P. W., Hill S. A., Foster J. L., Fowler J. F. Radiosensitization of C3H mouse mammary tumours using fractionated doses of x rays with the drug Ro-07-0582. Br J Radiol. 1976 Jan;49(577):76–80. doi: 10.1259/0007-1285-49-577-76. [DOI] [PubMed] [Google Scholar]
- THOMLINSON R. H., GRAY L. H. The histological structure of some human lung cancers and the possible implications for radiotherapy. Br J Cancer. 1955 Dec;9(4):539–549. doi: 10.1038/bjc.1955.55. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tallentire A., Jacobs G. P. Radiosensitization of bacterial spores by ketonic agents of differing electron-affinities. Int J Radiat Biol Relat Stud Phys Chem Med. 1972 Mar;21(3):205–213. doi: 10.1080/09553007214550241. [DOI] [PubMed] [Google Scholar]
- Thomlinson R. H., Dische S., Gray A. J., Errington L. M. Clinical testing of the radiosensitiser Ro-07-0582. III. Response of tumours. Clin Radiol. 1976 Apr;27(2):167–174. doi: 10.1016/s0009-9260(76)80139-0. [DOI] [PubMed] [Google Scholar]
